Skip to main content
Top

Open Access 23-03-2024 | Helicobacter Pylori | Case Report

Verrucous gastritis-like lesion in intramucosal Helicobacter pylori-uninfected signet ring cell carcinoma with poorly differentiated adenocarcinoma

Authors: Hiroki Takemoto, Takahiro Kotachi, Hajime Teshima, Hirosato Tamari, Akiyoshi Tsuboi, Hidenori Tanaka, Ken Yamashita, Yuji Urabe, Akira Ishikawa, Shiro Oka

Published in: Clinical Journal of Gastroenterology

Login to get access

Abstract

In Japan, accessible Helicobacter pylori (Hp) eradication therapy is associated with an increase in the prevalence of gastric cancers (GCs) in Hp uninfected stomachs. Signet ring cell carcinoma (SRCC) is the most common of these GCs. Intramucosal SRCC with poorly differentiated adenocarcinoma (PDA) occurring in Hp uninfected gastric mucosa is rare; furthermore, many Hp uninfected pure SRCCs exhibit discoloration and flat or slightly depressed lesions, and morphological elevation is relatively rare. We report a case of intramucosal SRCC with PDA with an elevated, verrucous gastritis-like lesion in a 57-year-old male patient. In the present case, the PDA area showed dense tumor cell growth and coexisting desmoplastic and fibrotic reactions. Histopathology and immunohistochemical staining identified extensive fibromuscular obliteration with smooth muscle bundles extending from the muscularis mucosa into the lamina propria. The patient underwent curative endoscopic submucosal dissection. The reporting and analysis of such rare cases may lead to a better understanding of the characteristics of advanced Hp uninfected GCs.
Literature
1.
go back to reference IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori IARC. Monogr Eval Carcinog Risks Hum 1994;61:241 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori IARC. Monogr Eval Carcinog Risks Hum 1994;61:241
2.
go back to reference Ono S, Kato M, Suzuki M, et al. Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion. 2012;86:59–65.CrossRefPubMed Ono S, Kato M, Suzuki M, et al. Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion. 2012;86:59–65.CrossRefPubMed
3.
go back to reference Matsuo T, Ito M, Takata S, et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 2011;16:415–9.CrossRefPubMed Matsuo T, Ito M, Takata S, et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 2011;16:415–9.CrossRefPubMed
4.
go back to reference Horiuchi Y, Fujisaki J, Yamamoto N, et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer. 2016;19:160–5.CrossRefPubMed Horiuchi Y, Fujisaki J, Yamamoto N, et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer. 2016;19:160–5.CrossRefPubMed
5.
go back to reference Kato S, Matsukura N, Tsukada K, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci. 2007;98:790–4.CrossRefPubMed Kato S, Matsukura N, Tsukada K, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci. 2007;98:790–4.CrossRefPubMed
6.
go back to reference Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011;16:382–8.CrossRefPubMed Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011;16:382–8.CrossRefPubMed
7.
go back to reference Yamada A, Kaise M, Inoshita N, et al. Characterization of Helicobacter pylori uninfected early gastric cancers. Digestion. 2018;98:127–34.CrossRefPubMed Yamada A, Kaise M, Inoshita N, et al. Characterization of Helicobacter pylori uninfected early gastric cancers. Digestion. 2018;98:127–34.CrossRefPubMed
8.
go back to reference Yamamoto Y, Fujisaki J, Omae M, et al. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27:551–61.CrossRefPubMed Yamamoto Y, Fujisaki J, Omae M, et al. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27:551–61.CrossRefPubMed
9.
go back to reference Okano A, Kato S, Ohana M. Helicobacter pylori-negative gastric cancer: advanced-stage undifferentiated adenocarcinoma located in the pyloric gland area. Clin J Gastroenterol. 2017;10:13–7.CrossRefPubMed Okano A, Kato S, Ohana M. Helicobacter pylori-negative gastric cancer: advanced-stage undifferentiated adenocarcinoma located in the pyloric gland area. Clin J Gastroenterol. 2017;10:13–7.CrossRefPubMed
10.
11.
go back to reference Shimada S, Mimata A, Sekine M, et al. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut. 2012;61:344–53.CrossRefPubMed Shimada S, Mimata A, Sekine M, et al. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut. 2012;61:344–53.CrossRefPubMed
12.
go back to reference Yagi K, Aruga Y, Nakamura A, et al. Regular arrangement of collecting venules (RAC): a characteristic endoscopic feature of Helicobacter pylori-negative normal stomach and its relationship with esophago-gastric adenocarcinoma. J Gastroenterol. 2005;40:443–52.CrossRefPubMed Yagi K, Aruga Y, Nakamura A, et al. Regular arrangement of collecting venules (RAC): a characteristic endoscopic feature of Helicobacter pylori-negative normal stomach and its relationship with esophago-gastric adenocarcinoma. J Gastroenterol. 2005;40:443–52.CrossRefPubMed
13.
go back to reference Kakinoki R, Kushima R, Matsubara A. Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases. Dig Dis Sci. 2009;54:614–20.CrossRefPubMed Kakinoki R, Kushima R, Matsubara A. Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases. Dig Dis Sci. 2009;54:614–20.CrossRefPubMed
14.
go back to reference Kiso M, Urabe Y, Ito M, et al. Clinical and genomic characteristics of mucosal signet-ring cell carcinoma in Helicobacter pylori-uninfected stomach. BMC Gastroenterol. 2020;20:243.CrossRefPubMedPubMedCentral Kiso M, Urabe Y, Ito M, et al. Clinical and genomic characteristics of mucosal signet-ring cell carcinoma in Helicobacter pylori-uninfected stomach. BMC Gastroenterol. 2020;20:243.CrossRefPubMedPubMedCentral
15.
go back to reference Sugihara H, Hattori T, Fukuda M, et al. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch A Pathol Anat Histopathol. 1987;411:117–27.CrossRefPubMed Sugihara H, Hattori T, Fukuda M, et al. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch A Pathol Anat Histopathol. 1987;411:117–27.CrossRefPubMed
16.
go back to reference Natsagdorj L, Sugihara H, Bamba M, et al. Intratumoural heterogeneity of intestinal expression reflects environmental induction and progression-related loss of induction in undifferentiated-type gastric carcinomas. Histopathology. 2008;53:685–97.CrossRefPubMed Natsagdorj L, Sugihara H, Bamba M, et al. Intratumoural heterogeneity of intestinal expression reflects environmental induction and progression-related loss of induction in undifferentiated-type gastric carcinomas. Histopathology. 2008;53:685–97.CrossRefPubMed
17.
go back to reference Yoshimura D, Yoshimura R, Kato S, et al. Clinical and pathological characteristics of Helicobacter pylori-uninfected signet-ring cell cancer of the stomach an analysis of case series. Stomach Intestine. 2020;55:1051–60. Yoshimura D, Yoshimura R, Kato S, et al. Clinical and pathological characteristics of Helicobacter pylori-uninfected signet-ring cell cancer of the stomach an analysis of case series. Stomach Intestine. 2020;55:1051–60.
18.
go back to reference Kishi K, Adachi K, Sakamoto U. Gastric flat elevated undifferentiated signet-ring cell mucosal cancer lesion detected in a case without Helicobacter pylori infection. Intern Med. 2023;10:10332. Kishi K, Adachi K, Sakamoto U. Gastric flat elevated undifferentiated signet-ring cell mucosal cancer lesion detected in a case without Helicobacter pylori infection. Intern Med. 2023;10:10332.
19.
go back to reference Misumi Y, Ichihara S, Nonaka K. Gastric signet-ring cell carcinoma that presented as an elevated lesion due to fibromuscular obliteration in the lamina propria. Case rep Gastrointest. 2021;2021:2887256. Misumi Y, Ichihara S, Nonaka K. Gastric signet-ring cell carcinoma that presented as an elevated lesion due to fibromuscular obliteration in the lamina propria. Case rep Gastrointest. 2021;2021:2887256.
20.
go back to reference Shiratori Y, Ikeya T, Suzuki K, et al. The rare case of elevated signet ring cell gastric carcinoma with Helicobacter pylori uninfected mucosa. Clin J Gastroenterol. 2020;13:736–9.CrossRefPubMed Shiratori Y, Ikeya T, Suzuki K, et al. The rare case of elevated signet ring cell gastric carcinoma with Helicobacter pylori uninfected mucosa. Clin J Gastroenterol. 2020;13:736–9.CrossRefPubMed
21.
go back to reference Murata M, Sugimoto M, Ban H, et al. Cap polyposis refractory to Helicobacter pylori eradication treated with endoscopic submucosal dissection. World J Gastrointest Endosc. 2017;9:529–34.CrossRefPubMedPubMedCentral Murata M, Sugimoto M, Ban H, et al. Cap polyposis refractory to Helicobacter pylori eradication treated with endoscopic submucosal dissection. World J Gastrointest Endosc. 2017;9:529–34.CrossRefPubMedPubMedCentral
22.
go back to reference Murawaki Y, Yashima K, Horie S, et al. Helicobacter pylori-negative gastric adenocarcinoma mimicking VG in the antrum: a case report and literature review. Intern Med. 2023;62:2063–9.CrossRefPubMed Murawaki Y, Yashima K, Horie S, et al. Helicobacter pylori-negative gastric adenocarcinoma mimicking VG in the antrum: a case report and literature review. Intern Med. 2023;62:2063–9.CrossRefPubMed
23.
go back to reference Takita M, Ohata K, Inamoto R, et al. Endoscopic and histological feature of Helicobacter pylori-negative differentiated gastric adenocarcinoma arising in antrum. JGH Open. 2021;5:4770–5.CrossRef Takita M, Ohata K, Inamoto R, et al. Endoscopic and histological feature of Helicobacter pylori-negative differentiated gastric adenocarcinoma arising in antrum. JGH Open. 2021;5:4770–5.CrossRef
24.
go back to reference Kotani S, Miyaoka Y, Fujiwara A, et al. Intestinal-type gastric adenocarcinoma without Helicobacter pylori infection successfully treated with endoscopic submucosal dissection. Clin J Gastroenterol. 2016;9:228–32.CrossRefPubMed Kotani S, Miyaoka Y, Fujiwara A, et al. Intestinal-type gastric adenocarcinoma without Helicobacter pylori infection successfully treated with endoscopic submucosal dissection. Clin J Gastroenterol. 2016;9:228–32.CrossRefPubMed
25.
go back to reference Ozaki Y, Suto H, Nasaka T, et al. A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype. Clin J Gastroenterol. 2015;8:18–21.CrossRefPubMed Ozaki Y, Suto H, Nasaka T, et al. A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype. Clin J Gastroenterol. 2015;8:18–21.CrossRefPubMed
26.
go back to reference Tsuji N, Umehara Y, Takenaka M, et al. Verrucous antral gastritis in relation to Helicobacter pylori infection, nutrition, and gastric atrophy. Gastroenterol Rep. 2019;8:293–8.CrossRef Tsuji N, Umehara Y, Takenaka M, et al. Verrucous antral gastritis in relation to Helicobacter pylori infection, nutrition, and gastric atrophy. Gastroenterol Rep. 2019;8:293–8.CrossRef
27.
go back to reference Oura R, Katayama Y, Gyotoku Y, et al. A case of undifferentiated intramucosal gastric cancer that exhibited elevated type. Dokkyo J Med Sci. 2016;43:125–9. Oura R, Katayama Y, Gyotoku Y, et al. A case of undifferentiated intramucosal gastric cancer that exhibited elevated type. Dokkyo J Med Sci. 2016;43:125–9.
28.
go back to reference Jeon HK, Lee SJ, Kim GH, et al. Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: short- and long-term outcomes. Surg Endosc. 2018;32:1963–70.CrossRefPubMed Jeon HK, Lee SJ, Kim GH, et al. Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: short- and long-term outcomes. Surg Endosc. 2018;32:1963–70.CrossRefPubMed
29.
go back to reference Kakushima N, Ono H, Tanaka M, et al. Factors related to lateral margin positivity for cancer in gastric specimens of endoscopic submucosal dissection. Dig Endosc. 2011;23:227–32.CrossRefPubMed Kakushima N, Ono H, Tanaka M, et al. Factors related to lateral margin positivity for cancer in gastric specimens of endoscopic submucosal dissection. Dig Endosc. 2011;23:227–32.CrossRefPubMed
30.
go back to reference Asada-Hirayama I, Kodashima S, Goto O, et al. Factors predictive of inaccurate determination of horizontal extent of intestinal-type early gastric cancers during endoscopic submucosal dissection: a retrospective analysis. Dig Endosc. 2013;25:593–600.CrossRefPubMed Asada-Hirayama I, Kodashima S, Goto O, et al. Factors predictive of inaccurate determination of horizontal extent of intestinal-type early gastric cancers during endoscopic submucosal dissection: a retrospective analysis. Dig Endosc. 2013;25:593–600.CrossRefPubMed
31.
go back to reference Horiuchi Y, Fujisaki J, Yamamoto N, et al. Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancers for magnifying endoscopy with narrow-band imaging: endoscopic submucosal dissection cases. Gastric Cancer. 2016;19:515–23.CrossRefPubMed Horiuchi Y, Fujisaki J, Yamamoto N, et al. Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancers for magnifying endoscopy with narrow-band imaging: endoscopic submucosal dissection cases. Gastric Cancer. 2016;19:515–23.CrossRefPubMed
32.
go back to reference Yamamoto Y, Fujisaki J, Hirasawa T, et al. Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 millimetres or less in diameter. Dig Endosc. 2010;22:112–8.CrossRefPubMed Yamamoto Y, Fujisaki J, Hirasawa T, et al. Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 millimetres or less in diameter. Dig Endosc. 2010;22:112–8.CrossRefPubMed
33.
go back to reference Yoshimizu S, Yamamoto Y, Horiuchi Y, et al. A suitable marking method to achieve lateral margin negative in endoscopic submucosal dissection for undifferentiated-type early gastric cancer. Endosc Int Open. 2019;7:274–81.CrossRef Yoshimizu S, Yamamoto Y, Horiuchi Y, et al. A suitable marking method to achieve lateral margin negative in endoscopic submucosal dissection for undifferentiated-type early gastric cancer. Endosc Int Open. 2019;7:274–81.CrossRef
34.
go back to reference Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33:4–20.CrossRefPubMed Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33:4–20.CrossRefPubMed
35.
go back to reference Okada K, Fujisaki J, Kasuga A, et al. Diagnosis of undifferentiated-type early gastric cancers by magnification endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2011;26:1262–9.CrossRefPubMed Okada K, Fujisaki J, Kasuga A, et al. Diagnosis of undifferentiated-type early gastric cancers by magnification endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2011;26:1262–9.CrossRefPubMed
Metadata
Title
Verrucous gastritis-like lesion in intramucosal Helicobacter pylori-uninfected signet ring cell carcinoma with poorly differentiated adenocarcinoma
Authors
Hiroki Takemoto
Takahiro Kotachi
Hajime Teshima
Hirosato Tamari
Akiyoshi Tsuboi
Hidenori Tanaka
Ken Yamashita
Yuji Urabe
Akira Ishikawa
Shiro Oka
Publication date
23-03-2024
Publisher
Springer Nature Singapore
Published in
Clinical Journal of Gastroenterology
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-024-01952-9
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.